FDA Examines Extreme Weather Impact On Device Supply Chains
This article was originally published in The Gray Sheet
Executive Summary
The agency called an advisory committee meeting and public comment period to collect feedback from device firms and others on effects that extreme weather and natural disasters pose to medical device safety and quality.
You may also be interested in...
FDA Panel Discusses Extreme Weather’s Effect On Medical Device Availability
FDA’s Device Good Manufacturing Practice Advisory Committee met April 11 to help the agency develop better policies to prepare for and respond to extreme weather conditions that impact medical devices.
HHS Innovation Project To Develop More Resilient DME For Natural Disasters
Over the next six to 12 months, a team working through HHS’ Innovation Fellows Program will develop medical technology capable of withstanding natural disasters.
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.